相关实验视频
Updated: May 21, 2025

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.0K
喘中的性别差异:omics证据和未来的方向
Bichen Peng1, Weiyi Ye1, Shuai Liu2
1College of Medical Information and Artificial Intelligence, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Frontiers in genetics
|March 20, 2025
概括
喘遗传学的性别差异尚未完全理解. 本综述探讨了omics的发现,以推进所有患者个性化喘治疗策略.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 呼吸系统药物 呼吸系统药物
- 精准医学是一门精准的医学.
背景情况:
- 喘是一种复杂的,异质的呼吸系统疾病,其患病率和严重程度因年龄和性别而异.
- 高通量"omics"技术为研究喘的遗传基础提供了新的途径.
- 目前的理解和临床指导方针缺乏对喘遗传机制的全面的性别特定见解.
研究的目的:
- 审查最近关于喘性差异的"omics"发现.
- 讨论多维omics数据的整合,以获得更深入的见解.
- 为了提高性别特异性喘管理的精度和有效性.
主要方法:
- 对OMICS级研究的文献综述,重点关注喘中的性别差异.
- 分析与喘有关的遗传,表观遗传和转录基因数据.
- 综合发现,以确定性别特定的模式和机制.
主要成果:
- 奥米克斯的数据显示了喘遗传结构的显著性别特异性变异.
- 这些差异影响疾病的易感性,进展和潜在的治疗反应.
- 目前的证据突出显示,在喘研究中需要进行性别分层分析.
结论:
- 进一步探索喘遗传学中的性别差异至关重要.
- 整合omics发现可以导致更精确,更有效的,性别特定的喘管理策略.
- 临床指导方针应考虑纳入性别特异性经验证据,以改善患者护理.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
204
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
204
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
298
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
298
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K

